Improvement in Liver Pathology of Patients With β-Thalassemia Treated With Deferasirox for at Least 3 Years

Yves Deugnier(Inserm), Pierre Brissot(Inserm), John B. Porter(Royal London Hospital), Bruno Turlin(Inserm), Maria Domenica Cappellini(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Louis Griffel(Novartis (United States)), Martine Ropert(Inserm), Yiyun Zhang, Vanessa Giannone(Novartis (United States))
Gastroenterology
August 27, 2011
Cited by 89


Related Papers